Wen Zhang

机构：Shandong University, Zhejiang Chem-tech Group (China), International Drug Development, Zhejiang University of Technology · ORCID：0000-0002-3247-9672

发表论文 100 篇 · 总被引 2982 次 · h-index 19

代表论文

• Current status of drugs targeting PDGF/PDGFR (2024 · Drug Discovery Today · 被引 33)
• Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial (2024 · Gastric Cancer · 被引 22)
• Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents (2024 · European Journal of Medicinal Chemistry · 被引 15)
• Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction (2024 · Bioorganic & Medicinal Chemistry · 被引 13)
• Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-l1 inhibitors (2024 · European Journal of Medicinal Chemistry · 被引 13)
• Advances in cancer immunotherapy using small-molecular inhibitors targeting the PD-1/PD-L1 interaction (2025 · Bioorganic & Medicinal Chemistry · 被引 11)